Homepage
Medication Guide
What Are the Purchase Channels for Dacomitinib?
Dacomitinib is a second-generation EGFR tyrosine kinase inhibitor, which has been approved in China for the first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). The drug ...
501
Monday, September 8th, 2025, 16:32
What Are the Purchasing Channels for Dacomitinib?
Dacomitinib, also known by other names such as Vizimpro, Dacoplice, is mainly used for the treatment of metastatic non-small cell lung cancer (NSCLC) with positive epidermal growth factor receptor (EG...
501
Monday, September 8th, 2025, 16:28
How to Purchase Dacomitinib
The original developer of Dacomitinib (Vizimpro) is Pfizer Inc. of the United States. It is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, widely ...
501
Monday, September 8th, 2025, 16:12
What is the 2025 Latest Price of Dacomitinib?
Dacomitinib, a second-generation EGFR tyrosine kinase inhibitor developed by Pfizer, is mainly used for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. As a key drug in target...
501
Monday, September 8th, 2025, 16:05
How to Buy Dacomitinib Cost-Effectively
Dacomitinib, also known by other names such as Vizimpro, Dacoplice, has multiple aliases. When purchasing Dacomitinib, patients and their family members will naturally seek the most cost-effective opt...
501
Monday, September 8th, 2025, 15:20
Purchase Channels of Dacomitinib
Dacomitinib, with the English name Dacomitinib, is a potent second-generation EGFR tyrosine kinase inhibitor. While patients and their family members focus on its therapeutic effects, they also need t...
501
Monday, September 8th, 2025, 15:12
How to Purchase Authentic Dacomitinib
Dacomitinib is a targeted therapeutic drug for non-small cell lung cancer (NSCLC) with positive EGFR mutations. As a second-generation irreversible EGFR tyrosine kinase inhibitor, it demonstrates sign...
501
Monday, September 8th, 2025, 15:05
Purchase Channels for Dacomitinib
The original research company of Dacomitinib (Vizimpro) is Pfizer Inc. of the United States. It is a highly effective second-generation EGFR tyrosine kinase inhibitor, mainly used for the treatment of...
501
Monday, September 8th, 2025, 14:32
Authentic Purchase Channels for Dacomitinib
Dacomitinib, with the English name Dacomitinib, is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. For patients to use this drug effectively, it is...
501
Monday, September 8th, 2025, 14:19
Medication Precautions for Dacomitinib
Dacomitinib is a targeted drug for non-small cell lung cancer (NSCLC) with positive EGFR mutations. Its medical insurance reimbursement status, medication precautions, and dietary coordination are of ...
501
Monday, September 8th, 2025, 14:12
3 / 85
849 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved